ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
3,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
3,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
4,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
4,2,Drug abuser,Drug and chemical abuse,Lifestyle issues,SocCi,N
4,3,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
5,1,Drug abuser,Drug and chemical abuse,Lifestyle issues,SocCi,N
5,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
6,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,2,Genital hypoaesthesia,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
6,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
